Navigation Links
Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
Date:2/18/2011

osition of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; to grow product revenue through the Company's specialty sales forces; and to maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates.

Safe Harbor StatementThis press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein, other than statements of historical fact, including statements regarding the progress and timing of our product development programs and related trials, our strategy and our future operations and opportunities, constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the results of preclinical studies and clinical trials with respect to our products under development, our ability to satisfy FDA and other regulatory requirements, our ability to enter into strategic licensing, product acquisition, collaboration or co-promotion transactions on favorable terms, if at all, and the other factors described in Item 1A (Risk Factors) of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the SEC) on March 4, 2010 and in our subsequent filings with the SEC. In addition, the statements in this press release reflect our expectations and beliefs as of the date of this release, should not be relied upon as representing our views as of any other date and do not reflect the potential impact of any acquisitions, mergers, dispositions, business development transactions, joint ventures or investments that we may make or enter into. We anticipate that subsequent events and developments will cause our expectations and beliefs to change. However, while we may elect
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
2. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
3. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
4. Cornerstone Therapeutics Announces Collaboration with The Cough Company
5. Cornerstone Therapeutics to Host Second Quarter 2010 Conference Call
6. Cornerstone Therapeutics Announces Management Change
7. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
8. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
9. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
10. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
11. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Aug. 30, 2014  Boston Scientific has released ... TherApy foR Heart Failure (NECTAR-HF) clinical trial, the ... vagus nerve stimulation (VNS) for the treatment of ... of Therapeutics and Cardiology and Director of the ... la Sante et de la Recherche Medicale presented ...
(Date:8/30/2014)... 2014   Royal Philips  (NYSE: PHG, AEX: PHIA) ... new ultrasound system designed to enable global hospitals and ... volumes and cost pressures. Making its debut at the  ... Barcelona this week, Affiniti provides innovative ... fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... 29, 2014 /PRNewswire-iReach/ -- Market Research Report on ... is a professional and in-depth market survey on ... . The report firstly reviews the basic information ... and manufacturing technology. The report then explores global ... listing their product specification, capacity, Production value, and ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO ... 2011. Total revenue was $2.4 million and $5.5 million ... $1.1 million and $2.5 million for the same periods in 2010. ... ended June 30, 2011, were $7.6 million and $15.0 million as ...
... Pharmaceutical Care Management Association (PCMA) President and CEO Mark ... new lawsuit by several drugstore lobbying groups to prevent ... "California could have sidestepped this litigation and ... by following Governor Andrew Cuomo,s (D-NY) example ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11PCMA: California Medicaid Could Save $2 Billion, Avoid Drugstore Litigation by Modernizing Medicaid Pharmacy 2
(Date:8/30/2014)... Ticket Down reports that ticket demand is high ... at Levi's Stadium. The summer months of 2014 have ... States due to the fact that so many international teams have ... Many of these games were practice games in preparation for the ... Stadium is a brand new facility that will be the home ...
(Date:8/30/2014)... August 30, 2014 Information supplied by ... to introduce better prices to consumers in 2014. A ... be found when using the open system for adults ... system available to use this year can help the ... on general location and not from medical histories. The ...
(Date:8/30/2014)... 30, 2014 United Theological Seminary is pleased ... degree, the Master of Theological Studies (MTS). ... is designed for students who wish to pursue further academic ... capacity to serve the Church and community. Previously, students needed ... they can attend classes from any location where there is ...
(Date:8/30/2014)... August 30, 2014 Hands ... Spa-on-Wheels which offers the complete spa experience combining ... lighting and the most important ingredient of all, ... dedicated licensed pro's! People will enjoy the get-away ... Kaplan-Pelle. The website reads, "Step into the spacious, ...
(Date:8/30/2014)... Patients suffering from vitiligo can now ... new review published by Daily Gossip. , Vitiligo ... there is no wonder that numerous sufferers search for ... Treatment is one of the most appreciated such methods ... to stop the spread of this disorder immediately, while ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Hands On Mobile Massage and Spa of Long Island Now Offers a Spa-on-wheels 2Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2
... 2008 As part of,its ongoing efforts to ... Relief and Development (LIFE), is preparing to,distribute high ... 20,medical schools and teaching hospitals in Iraq., ... American,non-governmental organization based in Pittsburgh, Pennsylvania, and the,Iraqi ...
... Persons with periodontitis who also are infected with ... developing tongue cancer, new research conducted at the ... shown., Periodontitis is a chronic inflammatory disease that ... It has been associated with various systemic diseases, ...
... Mich., April 4, 2008 Terumo Cardiovascular,Systems (Terumo ... a patent,infringement complaint by Maquet Cardiovascular LLC. The ... Terumo Corporation, had infringed,on two patents related to ... System., (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ), ...
... April 4, 2008 Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ... of its Hepatitis C program at the upcoming,Canaccord Adams ... 1:30,p.m. ET at the St. Regis Hotel in New ... the company presentation can be,accessed under "Calendar of Events" ...
... improve stability and balance in women over age 65, which ... of Temple Universitys Gait Study Center. , Dr. Jinsup Song ... College of Health Professions examined the gait and postural stability ... yoga program specifically designed for those over 65. They found ...
... read and the Internet links included in them opened, ... off! Recipients are more likely to access the information ... applies to important medical information sent to a large ... a study conducted at the Department of Clinical Pharmacology ...
Cached Medicine News:Health News:HPV, periodontitis work in tandem to increase risk of tongue cancer 2Health News:Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement 2Health News:Poses can prevent falls 2Health News:Poses can prevent falls 3Health News:E-mail design pays off 2
... Ziemer's FEMTO LDV, the first compact, mobile ... provide a versatile, powerful platform for a ... The basic system addresses the demand of ... that is consistent with an efficient LASIK ...
Stylish yet conservative, these classics are reliable, comfortable and durable....
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Inquire...
Medicine Products: